Structural and functional healing of critical‐size segmental bone defects by transduced muscle‐derived cells expressing BMP4
- 20 April 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (9) , 984-991
- https://doi.org/10.1002/jgm.588
Abstract
Background Our previous studies have shown that muscle‐derived cells, including a population of muscle stem cells, transduced with a retroviral vector expressing bone morphogenetic protein 4 (BMP4) can improve the healing of critical‐size calvarial defects. However, we did not evaluate the functionality of the healed bone. The purpose of this study was to determine whether primary muscle‐derived cells transduced with retroBMP4 can heal a long bone defect both structurally and functionally. Methods Primary muscle‐derived cells were genetically engineered to express BMP4 and were implanted into 7‐mm femoral defects created in syngeneic rats. Muscle‐derived cells transduced with retroLacZ were used in the control group. Bone healing was monitored by radiography, histology, and biomechanical testing at designated time points. Results Most of the defects treated with muscle‐derived cells expressing BMP4 formed bridging callous by 6 weeks after surgery, and exhibited radiographically evident union at 12 weeks after cell implantation. Histological analysis at 12 weeks revealed that the medullary canal of the femur was restored and the cortex was remodeled between the proximal and distal ends of each BMP4‐treated defect. In contrast, the defects treated with muscle‐derived cells expressing β‐galactosidase displayed nonunion at all tested time points. An evaluation of the maximum torque‐to‐failure in the treatment group indicated that the healed bones possessed 77 ± 28% of the strength of the contralateral intact femora. Torsional stiffness and energy‐to‐failure were not significantly different between the treated and intact limbs. Conclusions This study demonstrated that primary muscle‐derived cells transduced with retroBMP4 can elicit both structural and functional healing of critical‐size segmental long bone defects created in rats. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Converse Relationship Between In Vitro Osteogenic Differentiation and In Vivo Bone Healing Elicited by Different Populations of Muscle-Derived Cells Genetically Engineered to Express BMP4Journal of Bone and Mineral Research, 2004
- Synergistic enhancement of bone formation and healing by stem cell–expressed VEGF and bone morphogenetic protein-4Journal of Clinical Investigation, 2002
- Enhancement of Bone Healing Based onEx VivoGene Therapy Using Human Muscle-Derived Cells Expressing Bone Morphogenetic Protein 2Human Gene Therapy, 2002
- Development of an MFG-Based Retroviral Vector System for Secretion of High Levels of Functionally Active Human BMP4Molecular Therapy, 2001
- Osteoprogenitor cells within skeletal muscleJournal of Orthopaedic Research, 2000
- Gene Therapy-Directed Osteogenesis: BMP-7-Transduced Human Fibroblasts Form Bonein VivoHuman Gene Therapy, 2000
- In Vivo Endochondral Bone Formation Using a Bone Morphogenetic Protein 2 Adenoviral VectorHuman Gene Therapy, 1999
- Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivoJournal of Orthopaedic Research, 1999
- Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion ModelClinical Orthopaedics and Related Research, 1996
- The mineral and mechanical properties of bone in chronic experimental diabetesJournal of Orthopaedic Research, 1988